(R)-1-(tert-Butoxycarbonyl)-4-methylpiperazine-2-carboxylic acid, 97%, 250mg

N-benzyl-6-ethyl-1,3-benzothiazol-2-amine, 95.0%, 250mg

5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; but-2-enedioic acid, 97.0%, 500mg

3'-Methyl-2,2,2-trifluoroacetophenone, 97.0%, 25g

TERT-BUTYL 3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)AZETIDINE-1-CARBOXYLATE, 95.0%, 10g

D-GALACTOSE, 95.0%, 1g

4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid, 97%, 100mg

2,4-Dibromo-1-methoxynaphthalene, 95+%, 1g

Colonne capillaire GC ROTI®Cap-1, 25 m, 0,53 mm, 1,00 µm, 1 pièce(s)

4-amino-N-(2,3-dimethylphenyl)benzamide, 95.0%, 5g

(S)-Benzyl (2,6-dioxopiperidin-3-yl)carbamate, 95.0%, 100mg

5,6,7,8-Tetrahydroquinolin-6-amine hydrochloride, 1g

1H-Pyrazolo[4,3-c]pyridin-3-amine, 100mg